comscoreResearch News

Research News

Find out what the latest clinical trial results mean for you.
More from this topic
1386 Research news
Risk of Heart Problems Lower in Breast Cancer Survivors Who Exercise

Exercise helped reduce the risk of heart problems in women receiving treatment for breast cancer.

Hormone-Free Medicine for Hot Flashes Shows Promise

Fezolinetant, an experimental medicine that doesn’t contain hormones, has successfully treated hot flashes.

3D Mammograms Reduce Risk of Advanced-Stage Disease in Women With Extremely Dense Breasts and High Risk of Breast Cancer

In women with extremely dense breasts and a high risk of breast cancer, screening with 3D mammograms — rather than 2D digital mammograms — was linked to a lower risk of advanced-stage disease.

Black and Hispanic Women May Have Higher Risk of Lymphedema

Among women who had breast cancer surgery and axillary lymph node dissection, Black and Hispanic women were more likely to develop lymphedema than white women, as were women who received chemotherapy before surgery, rather than after surgery.

After DCIS, About One in Five Invasive Breast Cancers Unrelated to Original DCIS

In the years following a DCIS (ductal carcinoma in situ) diagnosis, about one in five invasive breast cancers that developed were not related to the original DCIS lesion.

Jun 16, 2022 | Diagnosis
Some Older Women With Luminal A Breast Cancer May Be Able To Skip Radiation After Lumpectomy

Women ages 55 and older diagnosed with early-stage, estrogen receptor-positive, progesterone receptor-positive, HER2-negative breast cancer that had low levels of Ki67 protein and a very low risk of recurrence were able to safely skip radiation after lumpectomy.

Jun 16, 2022 | Radiation Therapy and Diagnosis
Many Black Metastatic Breast Cancer Patients Never Informed About Clinical Trials

Many Black people diagnosed with metastatic breast cancer never find out about clinical trials from their doctors even though most of them are open to participating in one.

Jun 9, 2022 | Ethnicity and Diagnosis
Trodelvy Slightly Improves Progression-Free Survival for Pre-treated Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer

Trodelvy (chemical name: sacituzumab govitecan-hziy) slightly improved progression-free survival in people diagnosed with metastatic hormone receptor-positive, HER2-negative breast cancer previously treated with hormonal therapy, a CDK4/6 inhibitor, and multiple lines of chemotherapy.

Jun 9, 2022 | Targeted Therapy and Diagnosis
A New Standard of Care? Enhertu Improves Survival in People With Metastatic HER2-Low Breast Cancer

Compared with doctors’ choice of chemotherapy, Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) improved both progression-free survival and overall survival in people diagnosed with previously treated metastatic HER2-low breast cancer.

Lying Facedown for Radiation Therapy Causes Fewer Skin Side Effects in Women With Large Breasts

During external whole-breast radiation therapy for breast cancer, women with large breasts who lay facedown had fewer skin side effects than women who lay faceup.

ASCO Issues Guidelines on Exercise, Diet, and Weight Management During Cancer Treatment

Doctors should recommend regular aerobic and resistance exercise for people receiving cancer treatment.

May 26, 2022 | Exercise
Breast Cancer Treatment Linked to Increased Risk of Diabetes and High Blood Pressure

Women with a history of invasive breast cancer had a higher risk of developing high blood pressure and diabetes than women without a history of breast cancer.

May 26, 2022 | Diagnosis and Side Effects
Infertile Men May Have Much Higher Breast Cancer Risk

Infertility seems to double the risk of breast cancer in men.

Chemotherapy, Belly Fat, and Fitness Affect Vaccine Response in Breast Cancer Survivors

Previous chemotherapy treatment, more belly fat, and being less physically fit led to a lower immune response to a typhoid vaccine in women who’d been treated for breast cancer.

May 18, 2022 | Exercise and Chemotherapy
Vitamin D, Omega-3s, and Strength Exercises May Reduce Cancer Risk in Older People

Simple at-home strength exercises plus vitamin D and omega-3 supplements seemed to reduce cancer risk in healthy people age 70 and older.

May 12, 2022 | Risk Factors
Which Breast Cancer Surgery Offers Better Long-Term Quality of Life?

Women were satisfied with their breasts 10 years after either lumpectomy and radiation or mastectomy and reconstruction for early-stage breast cancer. Still, women who had lumpectomy and radiation had better psychosocial and sexual well-being.

May 6, 2022 | Surgery
FDA Approves Enhertu for Unresectable or Metastatic HER2-Low Breast Cancer

On Aug. 5, 2022, the U.S. Food and Drug Administration approved Enhertu to treat unresectable or metastatic HER2-low breast cancer.

21 hours ago
Breast Cancer Death Rate Decreases in Florida, but Still Highest for Black Women

Breast cancer death rates decreased among all racial and ethnic groups from 1990 to 2015 in Florida, but Black women were still twice as likely to die from breast cancer as white women.

Jul 8, 2021 | Ethnicity
Hearing Problems Common After Chemotherapy Treatment

Hearing loss and other hearing problems seem to be common in adults who’ve received chemotherapy for the four most common types of cancer, including breast cancer.

Jul 29, 2022 | Chemotherapy and Side Effects
HRT Doesn’t Seem To Raise Risk of Breast Cancer Recurrence in Certain Women

Overall, neither systemic nor vaginal hormone replacement therapy (HRT) seemed to increase the risk of breast cancer recurrence (the cancer coming back) in women diagnosed with early-stage, estrogen receptor-positive disease. Still, using vaginal HRT slightly increased recurrence risk in women who received an aromatase inhibitor.

Cases of Breast Implant-Related Cancer May Be More Than Double FDA Estimates

The number of U.S. cases of breast anaplastic large-cell lymphoma — a rare cancer linked to textured implants — may be twice as high as U.S. Food and Drug Administration estimates.

Jul 26, 2022 | Surgery and Reconstruction
Six Months After Second Pfizer Vaccine Dose, People With Solid Tumors Have Same COVID-19 Antibody Levels as People Without Cancer

Six months after receiving their second dose of the Pfizer COVID-19 vaccine, people diagnosed with solid tumor cancers had about the same antibody levels as people who hadn’t been diagnosed with cancer.

Kisqali-Faslodex Combo Continues To Improve Overall Survival in Advanced-Stage, Hormone-Receptor-Positive Breast Cancer in Postmenopausal Women

The latest results from the MONALEESA-3 study show that combining Kisqali plus Faslodex continues to offer better overall survival than Faslodex alone.

Study Finds No Link Between Fertility Treatments and Breast Cancer Risk

Medicines commonly used to stimulate the ovaries to release eggs during fertility treatment don’t seem to increase the risk of developing breast cancer.

Showing 24 of 1386